275 related articles for article (PubMed ID: 12833459)
61. The effect of prior exposure to imatinib on transplant-related mortality.
Deininger M; Schleuning M; Greinix H; Sayer HG; Fischer T; Martinez J; Maziarz R; Olavarria E; Verdonck L; Schaefer K; Boqué C; Faber E; Nagler A; Pogliani E; Russell N; Volin L; Schanz U; Doelken G; Kiehl M; Fauser A; Druker B; Sureda A; Iacobelli S; Brand R; Krahl R; Lange T; Hochhaus A; Gratwohl A; Kolb H; Niederwieser D;
Haematologica; 2006 Apr; 91(4):452-9. PubMed ID: 16585011
[TBL] [Abstract][Full Text] [Related]
62. [A new drug in the therapy of chronic myeloid leukemia: ST1571].
Salesi N; Bossone G; Della Longa G; Di Cocco B
Minerva Med; 2003 Apr; 94(2):71-6. PubMed ID: 12858155
[TBL] [Abstract][Full Text] [Related]
63. The onset of CML in blastic crisis: molecular features.
Gregorini A; Filippetti A; Luchetti F; Walker A; Lillington DM; Papa S; Valentini M
J Biol Regul Homeost Agents; 1997; 11(3):111-4. PubMed ID: 9498160
[TBL] [Abstract][Full Text] [Related]
64. Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Burke MJ; Trotz B; Luo X; Weisdorf DJ; Baker KS; Wagner JE; Verneris MR
Bone Marrow Transplant; 2009 Aug; 44(3):169-74. PubMed ID: 19204709
[TBL] [Abstract][Full Text] [Related]
65. Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience.
Pigneux A; Faberes C; Boiron JM; Mahon FX; Cony-Makhoul P; Agape P; Lounici A; Bernard P; Bilhou-Nabera C; Bouzgarrou R; Marit G; Reiffers J
Bone Marrow Transplant; 1999 Aug; 24(3):265-70. PubMed ID: 10455364
[TBL] [Abstract][Full Text] [Related]
66. Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma.
Kroschinsky F; Friedrich K; Hanel M; Mohr B; Langer T; Meinhardt M; Thiede C; Bornhauser M; Baretton G; Ehninger G
Ann Hematol; 2003 Jan; 82(1):47-52. PubMed ID: 12574966
[TBL] [Abstract][Full Text] [Related]
67. Advanced-phase chronic myeloid leukemia.
Cortes J; Kantarjian H
Semin Hematol; 2003 Jan; 40(1):79-86. PubMed ID: 12563614
[TBL] [Abstract][Full Text] [Related]
68. Current status and perspectives of tyrosine kinase inhibitor treatment in the posttransplant period in patients with chronic myelogenous leukemia (CML).
Klyuchnikov E; Kröger N; Brummendorf TH; Wiedemann B; Zander AR; Bacher U
Biol Blood Marrow Transplant; 2010 Mar; 16(3):301-10. PubMed ID: 19744571
[TBL] [Abstract][Full Text] [Related]
69. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey.
Arslan O; Gürman G; Dilek I; Ozcan M; Koç H; Ilhan O; Akan H; Konuk N; Uysal A; Beksaç M
Haematologia (Budap); 1998; 29(1):59-62. PubMed ID: 9704259
[TBL] [Abstract][Full Text] [Related]
70. Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia.
Kantarjian HM; O'Brien S; Cortes J; Giles FJ; Faderl S; Issa JP; Garcia-Manero G; Rios MB; Shan J; Andreeff M; Keating M; Talpaz M
Cancer; 2003 Aug; 98(3):522-8. PubMed ID: 12879469
[TBL] [Abstract][Full Text] [Related]
71. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome-positive leukemias with the T315I mutation.
Nicolini FE; Basak GW; Kim DW; Olavarria E; Pinilla-Ibarz J; Apperley JF; Hughes T; Niederwieser D; Mauro MJ; Chuah C; Hochhaus A; Martinelli G; DerSarkissian M; Duh MS; McGarry LJ; Kantarjian HM; Cortes JE
Cancer; 2017 Aug; 123(15):2875-2880. PubMed ID: 28387926
[TBL] [Abstract][Full Text] [Related]
72. Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Kantarjian HM; O'Brien S; Cortes JE; Giralt SA; Rios MB; Shan J; Giles FJ; Thomas DA; Faderl S; De Lima M; Garcia-Manero G; Champlin R; Arlinghaus R; Talpaz M
Blood; 2002 Sep; 100(5):1590-5. PubMed ID: 12176876
[TBL] [Abstract][Full Text] [Related]
73. [Granulocyte alkaline phosphatase activity in the chronic phase and blastic crisis of chronic myeloid leukemia. Sequential study of 43 patients].
Bosch F; Cervantes F; Rozman M; Terol MJ; Montserrat E; Rozman C
Sangre (Barc); 1992 Aug; 37(4):245-7. PubMed ID: 1514136
[TBL] [Abstract][Full Text] [Related]
74. [Causes of death in chronic myeloid leukemia. Analysis of 109 patients].
Cervantes F; Sanz C; Bosch F; Rozman C
Sangre (Barc); 1991 Jun; 36(3):183-6. PubMed ID: 1948535
[TBL] [Abstract][Full Text] [Related]
75. [Blast crisis of chronic myeloid leukemia with positive Philadelphia chromosome: course and clinico-hematologic profile in 80 patients].
Cervantes F; Rozman M; Salgado C; Vives-Corrons JL; Montserrat E; Rozman C
Med Clin (Barc); 1990 May; 94(18):681-4. PubMed ID: 2388491
[TBL] [Abstract][Full Text] [Related]
76. Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia.
Schmetzer HM; Gerhartz HH
Exp Hematol; 1997 Jun; 25(6):502-8. PubMed ID: 9197328
[TBL] [Abstract][Full Text] [Related]
77. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia.
Yamauchi K; Arimori S; Nagao T
Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659
[TBL] [Abstract][Full Text] [Related]
78. Clinical manifestations of chronic granulocytic leukemia.
Spiers AS
Semin Oncol; 1995 Aug; 22(4):380-95. PubMed ID: 7638635
[TBL] [Abstract][Full Text] [Related]
79. Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature.
Aguayo A; Cortes JE; Kantarjian HM; Beran M; Gandhi V; Plunkett W; Kurtzberg J; Keating MJ
Cancer; 1999 Jan; 85(1):58-64. PubMed ID: 9921974
[TBL] [Abstract][Full Text] [Related]
80. Access to stem cell transplantation: do women fare as well as men?
Mehta P; Pollock BH; Nugent M; Horowitz M; Wingard JR
Am J Hematol; 2003 Feb; 72(2):99-102. PubMed ID: 12555212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
